BRLSHIGH SIGNALFINANCIAL10-K

BRLS shows a dramatic reduction in deposits alongside substantial improvement in equity position, suggesting significant business model or capital structure changes.

The massive 85.7% decline in total deposits from $153M to $21.9M represents a fundamental shift in the company's operations or business focus. However, the substantial improvement in stockholders' equity position from -$7.4M to -$696K indicates meaningful progress toward financial stability, though the company remains in a net deficit position.

Comparing 2025-04-15 vs 2024-04-15View on EDGAR →
FINANCIAL ANALYSIS

The financial picture reveals a company undergoing significant transformation, with total deposits declining dramatically while the equity position improved substantially despite remaining negative. Operating expenses show mixed trends with SG&A growing modestly to $22.6M while R&D spending was meaningfully reduced. The reduction in capital expenditure alongside lower cash reserves suggests a more conservative operational approach during this transition period.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+90.6%
-$7.4M-$696K

Equity base grew 90.6% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Deposits
Balance Sheet
-85.7%
$153.0M$21.9M

Deposits declined 85.7% — significant outflows warrant immediate investigation into funding stability.

Capital Expenditure
Cash Flow
-63%
$4.5M$1.7M

Capex reduced 63% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

R&D Expense
P&L
-57.2%
$460K$197K

R&D spending cut 57.2% — could signal cost discipline or concerning reduction in innovation investment.

Cash & Equivalents
Balance Sheet
-39.4%
$1.1M$681K

Cash declined 39.4% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Liabilities
Balance Sheet
-30.3%
$87.1M$60.7M

Liabilities reduced 30.3% — deleveraging improves balance sheet strength and financial flexibility.

SG&A Expense
P&L
+21.2%
$18.6M$22.6M

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

Inventory
Balance Sheet
+15.9%
$6.9M$8.0M

Inventory built 15.9% — monitor whether demand supports this build or if write-downs may follow.

Accounts Receivable
Balance Sheet
+10.7%
$1.8M$2.0M

Receivables grew 10.7% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2025-04-15
PRIOR — 2024-04-15
ADDED
As of April 15, 2025, 21,378,890 Common Shares of the registrant, no par value, were issued and outstanding.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 40 ii Item 9.A.
As a result, although we believe our sources are reliable, we have not independently verified the information and cannot guarantee, or otherwise provide assurance on, its accuracy and completeness.
(the Company or Borealis Foods our, us or we ) contains statements that are forward-looking and as such are not historical facts.
This includes, without limitation, statements regarding the financial position, business strategy and the plans and objectives of management for future operations.
+7 more — sign up free →
REMOVED
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.
#104 Oakville , Ontario L6J 7W5 (Address of principal executive offices) (Zip Code) Registrant s telephone number, including area code: (905) 278-2200 Oxus Acquisition Corp.
As of March 22, 2024, 21,378,890 Common Shares of the registrant, no par, value were issued and outstanding.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 27 Item 9.A.
Principal Accountant Fees and Services 39 PART IV Item 15 Exhibits and Financial Statements Schedules 40 Item 16 Form 10-K Summary 41 Signatures 42 i BASIS OF PRESENTATION Borealis Foods Inc.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →